New Zealand

Time filter

Source Type

News Article | September 29, 2016
Site: www.altenergystocks.com

Debra Fiakas is the Managing Director of , an alternative research resource on small capitalization companies in selected industries. The U.S. Navy is laying claim to the first electric grid connected wave power generator in the country.  A test site has been set up near military facilities at Kaneohe Bay in the Hawaiian Islands, where wave activity is known to be exceptional.  Yes, Hawaii is part of the United States.  The project consists of two wave-power generation systems or ‘power buoys’ anchored about a half-mile off shore.  The two buoys are connected by undersea cable to the Marine Corps base at Kaneohe and ultimately to Oahu’s electric power grid.The first of the two buoys is produced by Northwest Energy Innovations .  Itswave energy device was first deployed at the Hawaii test site in June 2015.  The buoy sits atop the ocean with about 12 feet rising above the waves and another 50 feet extending below the surface.  The system weighs 45 tons and uses both up and down as well as side to side motions to generate electricity.  Northwest got help installing the Azura in Hawaii from a contractor, Sea Engineering, which also helped with the assembly and launch.  The Azura was developed in collaboration with Callaghan Innovation , a government agency of New Zealand and Energy Hydraulics Ltd ., also located in New Zealand.It seems that ‘takes a village’ to put a wave power buoy into the ocean.  The corrosive conditions of salt water and the dangers presented by the unpredictable waves and currents present significant challenges for engineers.  Device design, materials, anchoring and grid connections each present unique hurdles.The second buoy was developed by Fred. Olsen Ltd. based in Great Britain.  Its Lifesaver wave power system is a 50-foot wide and 3-feet thick doughnut-shaped device, which is anchored to the ocean floor by cables.  It is the action of the cables as the ocean moves that turns the generator.  The Lifesaver was put in place at the Hawaii site in April 2016, with help from Healy Tibbitts Builders and Sea Engineering, Inc. The smaller of the two buoys, the Lifesaver is expected to generate about 4 kilowatts.The Kaneohe projects is a first for the U.S., but not a first for the world.  The first grid-connected wave power station in the world was turned on in early 2015 of the coast of Western Australia by the device developer Carnegie Wave Energy Ltd CWE :  AUS or CWGYF:  OTC/QB).  There are limited ocean power grid connections in the United Kingdom and Norway as well.  The U.S. has remained behind developers in these areas where the engineering community has been quicker to embrace innovation and where public policy has been supportive of alternative energy development.  Over the past decade the U.S. military has invested about $300 million in hydrokinetic research and development, well behind investments in the United Kingdom, Australia and northern Europe.  The Hawaii project has been made possible by financial support from the U.S. Navy, which has interests in reducing energy costs at Hawaii military installations.The Navy will collect performance data from the Hawaii project in the coming months, which will be used to make adjustments to the power buoys installation as well as to the grid connections.  Northwest Energy Innovations also plans changes in its Azura power buoy to increase electric output from 20 kilowatts to 500 kilowatts.For now the companies involved in the Navy’s project in Hawaii are all privately held and are beyond the reach of most individual investors.  Wave power is still in the nascent stages and few ocean power projects underway anywhere have reached the point of generating power on a consistent basis.  Some investors might remember solar energy in the 1980s, when solar cells had been proven capable of generating electricity but had not consistently generated profits for any company.  With practical knowledge of system design, construction and operation accumulated, the early companies were eventually able to achieve scale and then began generating consistent income streams.The realization of a full and complete grid connection in Hawaii makes ocean power more certain for U.S. coastal markets.  In a study commissioned by the U.S. Department of Energy, RE Vision Consulting estimated that the theoretical ocean wave energy resource potential in the U.S. could satisfy more than 50% of the country’s annual demand.  This is a resource that cannot be ignored no matter how challenging the engineering work. Neither the author of the Small Cap Strategist web log, Crystal Equity Research nor its affiliates have a beneficial interest in the companies mentioned herein.


Patent
Callaghan Innovation and Southwest Scientific Editing & Consulting L.L.C. | Date: 2013-06-10

The invention relates to a feijoa fruit extract. In particular the invention relates to therapeutic uses of a feijoa fruit extract, processes for preparing the extract, and compositions comprising the extract. The feijoa fruit extract of the invention can be used in the treatment and prevention of rheumatoid arthritis and Type-2 diabetes.


Long N.J.,Callaghan Innovation
Entropy | Year: 2013

Maximum entropy inference can be used to find equations for the critical currents (Jc) in a type II superconductor as a function of temperature, applied magnetic field, and angle of the applied field, θ or φ. This approach provides an understanding of how the macroscopic critical currents arise from averaging over different sources of vortex pinning. The dependence of critical currents on temperature and magnetic field can be derived with logarithmic constraints and accord with expressions which have been widely used with empirical justification since the first development of technical superconductors. In this paper we provide a physical interpretation of the constraints leading to the distributions for Jc(T) and Jc(B), and discuss the implications for experimental data analysis. We expand the maximum entropy analysis of angular Jc data to encompass samples which have correlated defects at arbitrary angles to the crystal axes giving both symmetric and asymmetric peaks and samples which show vortex channeling behavior. The distributions for angular data are derived using combinations of first, second or fourth order constraints on cot θ or cot φ. We discuss why these distributions apply whether or not correlated defects are aligned with the crystal axes and thereby provide a unified description of critical currents in superconductors. For J//B we discuss what the maximum entropy equations imply about the vortex geometry. © 2013 by the authors.


Ingham B.,Callaghan Innovation
Journal of Applied Crystallography | Year: 2014

Spotty diffraction rings arise when the size distribution of crystallites illuminated by the incident beam includes crystallites that are large compared with the size of the beam. In this article, several statistical measures are used in conjunction to quantify spottiness and relate it to a crystallite size distribution: the number of peaks, the normalized root mean square intensity variation and the fractal dimension. These are demonstrated by way of example using synchrotron X-ray diffraction patterns collected during in situ corrosion of mild steel in carbon dioxide-saturated aqueous brine. © 2014 International Union of Crystallography.


Patent
Callaghan Innovation | Date: 2013-07-26

This invention relates to sphingoglycolipid analogues, compositions comprising these compounds, processes for preparing the compounds, and methods of treating or preventing diseases or conditions using the compounds, such as diseases or conditions relating to infection, atopic disorders, autoimmune disease, diabetes or cancer.


Patent
University of Liverpool and Callaghan Innovation | Date: 2012-03-09

The invention relates generally to oligosaccharide compounds and the use of these compounds as pharmaceuticals for treating diseases or conditions in which it is desirable to inhibit -secretase.


Patent
Yeshiva University and Callaghan Innovation | Date: 2013-08-07

Methods of treating infections due to Helicobacter pylori (H. pylori), in particular in subjects having a peptic ulcer, are disclosed where the methods comprise administering inhibitors of H. pylori MTAN (5-methylthioadenosine nucleosidase) to the subject.


Patent
Callaghan Innovation | Date: 2013-11-06

A cable winding machine for winding transposed cable from multiple serpentine subconductors such as in particular Roebel cable from such 2G HTS tape, without damaging the tape through edge-wise bending, comprises a conductor supply stage carrying subconductor supply spools to move the supply spools about a machine axis and maintain the supply spools in a common orientation as the subconductors unwind and move through the machine in a machine direction, and a cable forming stage after the conductor supply stage in the machine direction, arranged to bring together the subconductors and at which the subconductors interleave to form the transposed cable.


Patent
Callaghan Innovation | Date: 2012-11-30

An arm rehabilitation system for exercising a users arm. The system provides an arm support device moveable upon a support surface by a users first arm. The arm support device has a main body configured to movably engage the support surface on one side and has a hand support portion on an opposing side at or toward one end of the body for supporting a users hand of the first arm. A primary hand support formation protrudes from the hand support portion and a secondary hand support handle extends from the main body at or toward the periphery of the hand support portion. An adjustable switch support boom assembly is also mounted to the main body and has at least one operable user input component for generating an actuation signal in response to operation by the user. An onboard motion tracking system mounted to or within the main body is configured to sense motion of the main body to enable user interaction with an interactive computer system running an application program.


Patent
Callaghan Innovation | Date: 2013-12-06

The invention relates to sphingoglycolipid analogues and peptide derivatives thereof, which are useful in treating or preventing diseases or such as those relating to infection, atopic disorders, autoimmune diseases or cancer.

Loading Callaghan Innovation collaborators
Loading Callaghan Innovation collaborators